Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an impressive 21% year to date. Meanwhile, shares of its pharmaceutical rival Merck (NYSE: MRK) have lagged, down 8% in the same period.Amgen shareholders are celebrating, but have you wondered which stock is cheaper right now? Let's discuss whether Amgen or Merck stock offers better value.The price-to-earnings (P/E) ratio is a financial metric that divides a stock's price by its earnings per share (EPS) as a quick way to assess a company's valuation. A lower P/E ratio suggests the stock is cheaper relative to its earnings, though growth prospects and financial health add critical context.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool